0001406666-23-000041.txt : 20231030 0001406666-23-000041.hdr.sgml : 20231030 20231030170228 ACCESSION NUMBER: 0001406666-23-000041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231027 FILED AS OF DATE: 20231030 DATE AS OF CHANGE: 20231030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Collins John Matthew CENTRAL INDEX KEY: 0001887165 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34674 FILM NUMBER: 231361204 MAIL ADDRESS: STREET 1: C/O CALIX, INC. STREET 2: 2777 ORCHARD PARKWAY CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CALIX, INC CENTRAL INDEX KEY: 0001406666 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATION SERVICES, NEC [4899] IRS NUMBER: 680438710 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2777 ORCHARD PARKWAY CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 408-514-3000 MAIL ADDRESS: STREET 1: 2777 ORCHARD PARKWAY CITY: SAN JOSE STATE: CA ZIP: 95134 FORMER COMPANY: FORMER CONFORMED NAME: CALIX NETWORKS INC DATE OF NAME CHANGE: 20070713 4 1 wk-form4_1698699738.xml FORM 4 X0508 4 2023-10-27 0 0001406666 CALIX, INC (CALX) 0001887165 Collins John Matthew C/O CALIX, INC. 2777 ORCHARD PARKWAY SAN JOSE CA 95134 0 1 0 0 Chief Commercial Ops Officer 0 Common Stock 2023-10-27 4 M 0 15000 6.95 A 15000 D Common Stock 2023-10-27 4 M 0 15000 8.03 A 30000 D Common Stock 2023-10-27 4 M 0 30000 9.16 A 60000 D Common Stock 2023-10-27 4 S 0 60000 33.14 D 0 D Stock Option (right to buy) 6.95 2023-10-27 4 M 0 15000 0 D 2027-08-01 Common Stock 15000 20171 D Stock Option (right to buy) 8.03 2023-10-27 4 M 0 15000 0 D 2029-02-14 Common Stock 15000 25000 D Stock Option (right to buy) 9.16 2023-10-27 4 M 0 30000 0 D 2030-01-31 Common Stock 30000 165000 D Shares sold between $32.39 and $34.12 per share at a weighted average price of $33.14. The reporting person will provide full information regarding the number of shares sold at each sale price upon request. 80,000 of the shares subject to the option grant were fully vested and exercisable on July 17, 2021. 45,000 of the shares subject to the option grant were fully vested and exercisable on February 14, 2023. 175,000 of the shares subject to the option grant were fully vested and exercisable on July 31, 2023. /s/ Tom Gemetti as Attorney-in-Fact for John Matthew Collins 2023-10-30